They use exosomes to deliver the drug... which is where the 'link' to Exopharm comes in. No direct link to the company, but same technology. Last time news like this came out of Isreal, when they first started working on the technology, there was a huge jump in SP for EX1. Would be nice if the same occurred from this announcement.
88 patients, 0 intubated: Israeli ‘precision’ COVID drug wrapping up early trial, page-3
Add TYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.78M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 597934 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 250000 | 1 |
View Market Depth
| Last trade - 16.12pm 23/08/2024 (20 minute delay) ? |
| TYP (ASX) Chart |
Day chart unavailable